Clinical Validation of Digital PCR–Based ctDNA Detection for Risk Stratification in Residual Triple-Negative Breast Cancer: TRICIA Trial Results

These findings suggest that ctDNA testing using digital droplet PCR assays in an academic hospital-based context can reliably identify a very low-risk group of patients with non-pCR TNBC.